Erysipelas: Difference between revisions

Jump to navigation Jump to search
Line 15: Line 15:
{{Search infobox}}
{{Search infobox}}
{{CMG}}
{{CMG}}
==Diagnosis==
This disease is mainly diagnosed by the appearance of the rash and its characteristics. Blood cultures are unreliable for diagnosis of the disease, but may be used to test for [[sepsis]]. Erysipelas must be differentiated from [[herpes zoster]], [[angioedema]], [[contact dermatitis]], and diffuse inflammatory [[carcinoma]] of the breast.
Erysipelas can be distinguished from [[cellulitis]] by its raised advancing edges and sharp borders.
Elevation of the antistreptolysin O titre occurs after around 10 days of illness.


==Treatment==
==Treatment==

Revision as of 13:48, 16 October 2012

Erysipelas
ICD-10 A46.0
ICD-9 035
DiseasesDB 4428
MedlinePlus 000618
eMedicine derm/129 

Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Treatment

Depending on the severity, treatment involves either oral or intravenous antibiotics, using penicillins, clindamycin or erythromycin. While illness symptoms resolve in a day or two, the skin may take weeks to return to normal.

Complications

  • Spread of infection to other areas of body through the bloodstream (bacteremia), including septic arthritis and infective endocarditis (heart valves).
  • Septic shock.
  • Recurrence of infection – Erysipelas can recur in 18-30% of cases even after antibiotic treatment.
  • Lymphatic damage
  • Necrotizing fasciitis -- AKA "the flesh-eating bug." A potentially-deadly exacerbation of the infection if it spreads to deeper tissue.

Footnotes


External links

Template:Bacterial diseases
cs:Erysipel de:Erysipel eo:Erizipelo it:Erisipela lt:Rožė (liga) nl:Erysipelas no:Erysipelas fi:Ruusu (sairaus) sv:Rosfeber

Template:WH Template:WS